Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Debt / NOTE 4.000% 2/0
-
Market price (% of par)
-
88.1%
-
Total 13F principal
-
$264,043,019
-
Principal change
-
-$17,119,995
-
Total reported market value
-
$231,639,017
-
Number of holders
-
39
-
Value change
-
-$16,302,067
-
Number of buys
-
13
-
Number of sells
-
15
Institutional Holders of PDL BIOPHARMA INC - NOTE 4.000% 2/0 as of Q3 2015
As of 30 Sep 2015,
PDL BIOPHARMA INC - NOTE 4.000% 2/0 was held by
39 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$264,043,019
in principal (par value) of the bond.
The largest 10 bondholders included
UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, WOLVERINE ASSET MANAGEMENT LLC, CNH PARTNERS LLC, ADVENT CAPITAL MANAGEMENT /DE/, WELLS FARGO & COMPANY/MN, BASSO CAPITAL MANAGEMENT, L.P., PIONEER INVESTMENT MANAGEMENT INC, OAKTREE CAPITAL MANAGEMENT LP, SILVERBACK ASSET MANAGEMENT LLC, and ZAZOVE ASSOCIATES LLC.
This page lists
39
institutional bondholders reporting positions
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.